CSL Ltd. Newsletter
-
CSL, other big drugmakers could be Trump’s next targets
07 Apr 2025 06:52 GMT
CSL and some of the country’s other big pharmaceutical companies could be …
-
Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved
04 Apr 2025 21:49 GMT
… Pharmaceuticals and Jounce Therapeutics and amassed stakes in other struggling drugmakers … their condition after maker CSL Behring and a national … price. The therapy, which CSL sells as Hemgenix, was … European Union in 2023. CSL has already secured access …
-
Health Check: Liberation Day spares the global drug sector – for now
03 Apr 2025 04:31 GMT
… drugs go, tariffs are most relevant for European big pharma … : CSL (ASX:CSL).
With Americans decidedly grumpy with our Pharmaceutical Benefits … expected US Food and Drug Administration approval of its … on cancer trials
Oncology drug developer Race Oncology (ASX …
-
CSL survives a brutal sell-off but dips on US tariff response as investors eye pharma risk
03 Apr 2025 04:10 GMT
… receive exclusive market insights
CSL Ltd (ASX:CSL) has seen shares … impose a baseline tariff on pharmaceutical products.
But absent from … around the world through CSL’s channels, which could … the US administration,” CSL wrote on Thursday.
CSL last traded at …
-
Germany will reimburse haemophilia gene therapy Hemgenix
03 Apr 2025 18:43 GMT
CSL Behring has added another major … Germany," said Stefan Neudoerfer, CSL Behring's chief negotiator … not needed to take FIX drugs for several years.
In February … and several other world markets. CSL Behring, which launched the therapy …
-
11 popular ASX 200 shares crashing to multi-year lows amid market carnage
07 Apr 2025 11:06 GMT
… is no company news from CSL today. However, last week, the … the US tariffs. CSL said: At this stage pharmaceutical products are not … subject to the reciprocal tariffs. CSL is …
-
Expert Consensus on Vitamin B6 Therapeutic Use for Patients: Guidance on Safe Dosage, Duration and Clinical Management
07 Apr 2025 09:01 GMT
… Ipsen, Biogen, AstraZeneca, Eisai, CSL Behring and Novartis. JN received … Myers Squibb (BMS Medical), CSL Behring, Pfizer, Boehringer-Ingelheim, Terumo … ;bioequivalence-studies-pharmacokinetic-endpoints-drugs-submitted-under-abbreviated-new-drug?utm_medium= …
-
AARON PATRICK: Without a bailout from the Federal Reserve, the outlook for shares looks grim
07 Apr 2025 08:12 GMT
… Tino’s iron ore, CSL’s drugs, and Macquarie Group’s financial …
-
Health Check: We’re ‘duty free’, declare several ASX life science companies
07 Apr 2025 04:32 GMT
… investors its US Food and Drug Administration (FDA) approved treatment for … Thursday’s Liberation Day, CSL (ASX:CSL) affirmed that “pharmaceutical products” – read the … preclinical (rodent) studies of its drug candidate Cymerus shows the potential …
-
Murali Penmetsa: “Learning Management Systems are a Global Education Solution for the Future”
05 Apr 2025 08:23 GMT
… companies such as Capgemini America, CSL Seqirus, Luxottica Retail North America … businesses in various industries, whether pharmaceuticals or optical stores, achieve incredible … America, Charles River Laboratories, and CSL Seqirus not only improve internal …